N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography

NCT00830193 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Contrast Induced Nephropathy
Critically Ill

Interventions

DRUG: N-acetylcysteine
DRUG: D5W Placebo

Sponsor

Unity Health Toronto

Collaborators

[object Object]
[object Object]